Cdk5: Mediator of neuronal development, death and the response to DNA damage

Mechanisms of Ageing and Development

Volumn 132, Issue 8-9, 2011, Pages 389-394

  Zhu, Jinqiu ^a   Li, Wenming ^a   Mao, Zixu ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cdk5; Cell death; Central nervous system; DNA damage; Neurodegenerative disease

Indexed keywords

ATM PROTEIN; CALPASTATIN; CD146 ANTIGEN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLINE; EARLY GROWTH RESPONSE FACTOR 1; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE H2AX; MITOGEN ACTIVATED PROTEIN KINASE 12; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; P 5; PARKIN; PEPTIDE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P25; PROTEIN P35; PROTEIN P39; PROTEIN P53; ROSCOVITINE; SMALL INTERFERING RNA; STAT3 PROTEIN; SYNAPSIN I; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DNA DAMAGE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUNTINGTON CHOREA; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL MOVEMENT; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 5; DNA DAMAGE; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; SYNAPTIC TRANSMISSION;

EID: 80053107856     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.04.011     Document Type: Article

References (110)

1. Alvira D., Ferrer I., Gutierrez-Cuesta J., Garcia-Castro B., Pallas M., Camins A. Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease. Parkinsonism Relat. Disord. 2008, 14:309-313.
2. Anne S.L., Saudou F., Humbert S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J. Neurosci. 2007, 27:7318-7328.
3. Avraham E., Rott R., Liani E., Szargel R., Engelender S. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J. Biol. Chem. 2007, 282:12842-12850.
4. Benavides D.R., Bibb J.A. Role of Cdk5 in drug abuse and plasticity. Ann. N. Y. Acad. Sci. 2004, 1025:335-344.
5. Bibb J.A. Role of Cdk5 in neuronal signaling, plasticity, and drug abuse. Neurosignals 2003, 12:191-199.
6. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601.
7. Cai R.L., Yan-Neale Y., Cueto M.A., Xu H., Cohen D. HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. J. Biol. Chem. 2000, 275:27909-27916.
8. Caldecott K.W. DNA single-strand breaks and neurodegeneration. DNA Repair (Amst.) 2004, 3:875-882.
9. Cerna D., Camphausen K., Tofilon P.J. Histone deacetylation as a target for radiosensitization. Curr. Top. Dev. Biol. 2006, 73:173-204.
10. Chae T., Kwon Y.T., Bronson R., Dikkes P., Li E., Tsai L.H. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18:29-42.
11. Cheung Z.H., Gong K., Ip N.Y. Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J. Neurosci. 2008, 28:4872-4877.
12. Cheung Z.H., Ip N.Y. The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2007, 2:949-957.
13. Ching Y.P., Pang A.S., Lam W.H., Qi R.Z., Wang J.H. Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J. Biol. Chem. 2002, 277:15237-15240.
14. Chung S.-H. Cyclin-dependent kinase 5: a critical regulator of neurotransmitter release. Cyclin Dependent Kinase 5 2008, Springer. N.Y. Ip, L.-H. Tsai (Eds.).
15. Courapied S., Sellier H., de Carne Trecesson S., Vigneron A., Bernard A.C., Gamelin E., Barre B., Coqueret O. The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition. J. Biol. Chem. 2010, 285:26765-26778.
16. Cruz J.C., Kim D., Moy L.Y., Dobbin M.M., Sun X., Bronson R.T., Tsai L.H. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 2006, 26:10536-10541.
17. Dhariwala F.A., Rajadhyaksha M.S. An unusual member of the Cdk family: Cdk5. Cell Mol. Neurobiol. 2008, 28:351-369.
18. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell. Biol. 2001, 2:749-759.
19. Dobosy J.R., Selker E.U. Emerging connections between DNA methylation and histone acetylation. Cell. Mol. Life Sci. 2001, 58:721-727.
20. Evans A.R., Limp-Foster M., Kelley M.R. Going APE over ref-1. Mutat. Res. 2000, 461:83-108.
21. Fischer A., Sananbenesi F., Pang P.T., Lu B., Tsai L.H. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 2005, 48:825-838.
22. Fischer A., Sananbenesi F., Schrick C., Spiess J., Radulovic J. Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 2002, 22:3700-3707.
23. Flaherty D.B., Soria J.P., Tomasiewicz H.G., Wood J.G. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J. Neurosci. Res. 2000, 62:463-472.
24. Fu A.K., Fu W.Y., Cheung J., Tsim K.W., Ip F.C., Wang J.H., Ip N.Y. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat. Neurosci. 2001, 4:374-381.
25. Fu A.K., Ip F.C., Fu W.Y., Cheung J., Wang J.H., Yung W.H., Ip N.Y. Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15224-15229.
26. Fu W.Y., Wang J.H., Ip N.Y. Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation. J. Neurochem. 2002, 81:646-654.
27. Gilmore E.C., Ohshima T., Goffinet A.M., Kulkarni A.B., Herrup K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 1998, 18:6370-6377.
28. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L.A., Marshall J., Mao Z. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003, 38:33-46.
29. Guidato S., McLoughlin D.M., Grierson A.J., Miller C.C. Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. J. Neurochem. 1998, 70:335-340.
30. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
31. Han Y.H., Kim H.S., Kim J.M., Kim S.K., Yu D.Y., Moon E.Y. Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. FEBS Lett. 2005, 579:4897-4902.
32. Hellmich M.R., Pant H.C., Wada E., Battey J.F. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10867-10871.
33. Huang E., Qu D., Zhang Y., Venderova K., Haque M.E., Rousseaux M.W., Slack R.S., Woulfe J.M., Park D.S. The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nat. Cell Biol. 2010, 12:563-571.
34. Ikiz B., Przedborski S. A sequel to the tale of p25/Cdk5 in neurodegeneration. Neuron 2008, 60:731-732.
35. Imahori K., Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. 1997, 121:179-188.
36. Ishiguro K., Hisanga S.-I. The kinase activity of Cdk5 and its regulation. Cyclin Dependent Kinase 5 2008, 171-190. Springer. L.-H. Tsai, N.Y. Ip (Eds.).
37. Kamei H., Saito T., Ozawa M., Fujita Y., Asada A., Bibb J.A., Saido T.C., Sorimachi H., Hisanaga S. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J. Biol. Chem. 2007, 282:1687-1694.
38. Kanungo J., Zheng Y.L., Amin N.D., Pant H.C. Targeting Cdk5 activity in neuronal degeneration and regeneration. Cell. Mol. Neurobiol. 2009, 29:1073-1080.
39. Kim D., Frank C.L., Dobbin M.M., Tsunemoto R.K., Tu W., Peng P.L., Guan J.S., Lee B.H., Moy L.Y., Giusti P., Broodie N., Mazitschek R., Delalle I., Haggarty S.J., Neve R.L., Lu Y., Tsai L.H. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 2008, 60:803-817.
40. Kim Y., Sung J.Y., Ceglia I., Lee K.W., Ahn J.H., Halford J.M., Kim A.M., Kwak S.P., Park J.B., Ho Ryu S., Schenck A., Bardoni B., Scott J.D., Nairn A.C., Greengard P. Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 2006, 442:814-817.
41. Ko J., Humbert S., Bronson R.T., Takahashi S., Kulkarni A.B., Li E., Tsai L.H. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 2001, 21:6758-6771.
42. Lagace D.C., Benavides D.R., Kansy J.W., Mapelli M., Greengard P., Bibb J.A., Eisch A.J. Cdk5 is essential for adult hippocampal neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18567-18571.
43. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21:2672-2681.
44. Lai K.O., Ip N.Y. Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim. Biophys. Acta 2009, 1792:741-745.
45. Lambert de Rouvroit C., Goffinet A.M. Neuronal migration. Mech. Dev. 2001, 105:47-56.
46. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
47. Lee J.H., Kim H.S., Lee S.J., Kim K.T. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J. Cell Sci. 2007, 120:2259-2271.
48. Lew J., Winkfein R.J., Paudel H.K., Wang J.H. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J. Biol. Chem. 1992, 267:25922-25926.
49. Li B.S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A.B., Pant H.C. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 2002, 21:324-333.
50. Liebl J., Weitensteiner S.B., Vereb G., Takacs L., Fuerst R., Vollmar A.M., Zahler S. Cyclin dependent kinase 5 (Cdk5) regulates endothelial cell migration and angiogenesis. J. Biol. Chem. 2010.
51. Lim A.C., Hou Z., Goh C.P., Qi R.Z. Protein kinase CK2 is an inhibitor of the neuronal Cdk5 kinase. J. Biol. Chem. 2004, 279:46668-46673.
52. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 2001, 305:217-228.
53. Liu R., Tian B., Gearing M., Hunter S., Ye K., Mao Z. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7570-7575.
54. Low F.M., Hampton M.B., Winterbourn C.C. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid. Redox Signal. 2008, 10:1621-1630.
55. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
56. Mao Z., Yang Q. Regulation and function of Cdk5 in the nucleus. Cyclin Dependent Kinase 5 2008, Springer. L.-H. Tsai, N.Y. Ip (Eds.).
57. Matsunaga Y. Expression of cyclin E in postmitotic cells in the central nervous system. Kokubyo Gakkai Zasshi 2000, 67:169-181.
58. Mattson M.P., Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 2006, 7:278-294.
59. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep. 2004, 5:772-776.
60. Meyerson M., Enders G.H., Wu C.L., Su L.K., Gorka C., Nelson C., Harlow E., Tsai L.H. A family of human cdc2-related protein kinases. EMBO J. 1992, 11:2909-2917.
61. Mocko J.B., Kern A., Moosmann B., Behl C., Hajieva P. Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease. Neurobiol. Dis. 2010, 40:120-129.
62. Morfini G., Szebenyi G., Brown H., Pant H.C., Pigino G., DeBoer S., Beffert U., Brady S.T. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 2004, 23:2235-2245.
63. Nguyen C., Bibb J.A. Cdk5 and the mystery of synaptic vesicle endocytosis. J. Cell Biol. 2003, 163:697-699.
64. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 1996, 10:816-825.
65. Ogata A., Tashiro K., Nukuzuma S., Nagashima K., Hall W.W. A rat model of Parkinson's disease induced by Japanese encephalitis virus. J. Neurovirol. 1997, 3:141-147.
66. Ohshima T., Ogawa M., Veeranna, Hirasawa M., Longenecker G., Ishiguro K., Pant H.C., Brady R.O., Kulkarni A.B., Mikoshiba K. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2764-2769.
67. Ohshima T., Ogura H., Tomizawa K., Hayashi K., Suzuki H., Saito T., Kamei H., Nishi A., Bibb J.A., Hisanaga S., Matsui H., Mikoshiba K. Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J. Neurochem. 2005, 94:917-925.
68. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna, Pant H.C., Brady R.O., Martin L.J., Kulkarni A.B. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11173-11178.
69. Paglini G., Caceres A. The role of the Cdk5-p35 kinase in neuronal development. Eur. J. Biochem. 2001, 268:1528-1533.
70. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Ferreira A., Caceres A. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J. Neurosci. 1998, 18:9858-9869.
71. Pareek T.K., Keller J., Kesavapany S., Agarwal N., Kuner R., Pant H.C., Iadarola M.J., Brady R.O., Kulkarni A.B. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:660-665.
72. Pareek T.K., Kulkarni A.B. Cdk5, a journey from brain to pain: lessons from gene targeting. Cyclin Dependent Kinase 5 2008, Springer. L.-H. Tsai, N.Y. Ip (Eds.).
73. Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
74. Piedrahita D., Hernandez I., Lopez-Tobon A., Fedorov D., Obara B., Manjunath B.S., Boudreau R.L., Davidson B., Laferla F., Gallego-Gomez J.C., Kosik K.S., Cardona-Gomez G.P. Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. J. Neurosci. 2010, 30:13966-13976.
75. Plattner, F., Giese, K.P., Angelo, M., 2008. Involvement of Cdk5 in Synaptic Plasticity, and Learning and Memory. In: Tsai, L.-H., Ip, N.Y. (Eds.), Cyclin Dependent Kinase 5.
76. Qu D., Rashidian J., Mount M.P., Aleyasin H., Parsanejad M., Lira A., Haque E., Zhang Y., Callaghan S., Daigle M., Rousseaux M.W., Slack R.S., Albert P.R., Vincent I., Woulfe J.M., Park D.S. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 2007, 55:37-52.
77. Rass U., Ahel I., West S.C. Defective DNA repair and neurodegenerative disease. Cell 2007, 130:991-1004.
78. Rayman J.B., Takahashi Y., Indjeian V.B., Dannenberg J.H., Catchpole S., Watson R.J., te Riele H., Dynlacht B.D. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 2002, 16:933-947.
79. Rhee S.G., Yang K.S., Kang S.W., Woo H.A., Chang T.S. Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signal. 2005, 7:619-626.
80. Rimer M. Neuregulins: primary or secondary signals for the control of synapse-specific gene expression. J. Neurocytol. 2003, 32:665-675.
81. Rosales J., Han B., Lee K.Y. Cdk7 functions as a cdk5 activating kinase in brain. Cell Physiol. Biochem. 2003, 13:285-296.
82. Rosales J.L., Lee K.Y. Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 2006, 28:1023-1034.
83. Sakaue F., Saito T., Sato Y., Asada A., Ishiguro K., Hasegawa M., Hisanaga S. Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J. Biol. Chem. 2005, 280:31522-31529.
84. Sato K., Zhu Y.S., Saito T., Yotsumoto K., Asada A., Hasegawa M., Hisanaga S. Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35. J. Neurosci. Res. 2007, 85:3071-3078.
85. Segura Aguilar J., Kostrzewa R.M. Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox. Res. 2004, 6:615-630.
86. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K., Singh T.J. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 1997, 167:99-105.
87. Shelton S.B., Johnson G.V. Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 2004, 88:1313-1326.
88. Slevin M., Krupinski J. Cyclin-dependent kinase-5 targeting for ischaemic stroke. Curr. Opin. Pharmacol. 2009, 9:119-124.
89. Smith D.S., Greer P.L., Tsai L.H. Cdk5 on the brain. Cell Growth Differ. 2001, 12:277-283.
90. Smith D.S., Tsai L.H. Cdk5 behind the wheel: a role in trafficking and transport?. Trends Cell Biol. 2002, 12:28-36.
91. Smith P.D., Crocker S.J., Jackson-Lewis V., Jordan-Sciutto K.L., Hayley S., Mount M.P., O'Hare M.J., Callaghan S., Slack R.S., Przedborski S., Anisman H., Park D.S. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13650-13655.
92. Smith P.D., Mount M.P., Shree R., Callaghan S., Slack R.S., Anisman H., Vincent I., Wang X., Mao Z., Park D.S. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 2006, 26:440-447.
93. Steinhilb M.L., Dias-Santagata D., Mulkearns E.E., Shulman J.M., Biernat J., Mandelkow E.M., Feany M.B. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res. 2007, 85:1271-1278.
94. Stiegler P., De Luca A., Bagella L., Giordano A. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res. 1998, 58:5049-5052.
95. Sun K.H., de Pablo Y., Vincent F., Shah K. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J. Neurochem. 2008, 107:265-278.
96. Tan T.C., Valova V.A., Malladi C.S., Graham M.E., Berven L.A., Jupp O.J., Hansra G., McClure S.J., Sarcevic B., Boadle R.A., Larsen M.R., Cousin M.A., Robinson P.J. Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 2003, 5:701-710.
97. Tang X., Wang X., Gong X., Tong M., Park D., Xia Z., Mao Z. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 2005, 25:4823-4834.
98. Tian B., Yang Q., Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat. Cell Biol. 2009, 11:211-218.
99. Tomizawa K., Sunada S., Lu Y.F., Oda Y., Kinuta M., Ohshima T., Saito T., Wei F.Y., Matsushita M., Li S.T., Tsutsui K., Hisanaga S., Mikoshiba K., Takei K., Matsui H. Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 2003, 163:813-824.
100. Uchida Y., Ohshima T., Sasaki Y., Suzuki H., Yanai S., Yamashita N., Nakamura F., Takei K., Ihara Y., Mikoshiba K., Kolattukudy P., Honnorat J., Goshima Y. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005, 10:165-179.
101. Vanlerberghe G.C., Robson C.A., Yip J.Y. Induction of mitochondrial alternative oxidase in response to a cell signal pathway down-regulating the cytochrome pathway prevents programmed cell death. Plant Physiol. 2002, 129:1829-1842.
102. Wang K.K., Yuen P.W. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Sci. 1994, 15:412-419.
103. Xie Z., Tsai L.H. Cdk5 phosphorylation of FAK regulates centrosome-associated miocrotubules and neuronal migration. Cell Cycle 2004, 3:108-110.
104. Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992, 71:505-514.
105. Zhang J., Li H., Yabut O., Fitzpatrick H., D'Arcangelo G., Herrup K. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J. Neurosci. 2010, 30:5219-5228.
106. Zheng M., Leung C.L., Liem R.K. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 1998, 35:141-159.
107. Zheng Y.L., Amin N.D., Hu Y.F., Rudrabhatla P., Shukla V., Kanungo J., Keshavpany S., Grant P., Albers W., Pant H.C. A 24 residue peptide (P5), derived from P35, the CDK5 neuronal activator, specifically inhibits CDK5/P25 hyperactivity and tau hyperphosphorylation. J. Biol. Chem. 2010.
108. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005, 24:209-220.
109. Zheng Y.L., Li B.S., Kanungo J., Kesavapany S., Amin N., Grant P., Pant H.C. Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol. Biol. Cell 2007, 18:404-413.
110. Zhu Y.S., Saito T., Asada A., Maekawa S., Hisanaga S. Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation. J. Neurochem. 2005, 94:1535-1545.